🔎 Trials Near Me

Akèy › Dematomiyozit › New York › New York City

Etid klinik pou Dematomiyozit nan New York City, NY

5 etid pou Dematomiyozit ap chèche patisipan nan sit nan ak bò kote New York City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Ap rekriteFaz 1
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • NYP/Weill Cornell Medical Center, New York
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT03816345

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

Ap rekriteFaz 2/3
  • Hospital for Special Surgery - Accepting Adult and Juvenile Patients, New York
  • Memorial Sloan Kettering Cancer Center - Accepting Adult and Juvenile Patients, New York
Laj 6 a 75 · Tout sèks · Mizajou Sep 17, 2026 · NCT06154252

A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]

Ap rekriteFaz 3
  • NYU Langone Health - Clinical and Translational Science Institute Research Pharmacy, New York
  • NYU Langone Health Clinical Research Center, New York
  • NYU Langone Health, New York
  • ak 3 plis
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT05895786

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Ap rekriteFaz 1
  • Icahn School of Medicine at Mount Sinai, New York
Laj 18 a 74 · Tout sèks · Mizajou Sep 10, 2026 · NCT07085104

Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty

Ap rekriteFaz 2
  • NYU Langone Health, New York
Laj 18 ak plis · Tout sèks · Mizajou Jul 9, 2026 · NCT07138898

Etid Dematomiyozit nan lòt vil

Lòt etid nan New York City

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.